This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Galderma S.a.. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Roquefort les Pins, FR (2013)
- Rouquefort les Pins, FR (2015 - 2016)
Company Filing History:
Years Active: 2013-2016
Title: The Innovations of Philippe Bouissou
Introduction
Philippe Bouissou is a notable inventor based in Rouquefort les Pins, France. He has made significant contributions to the field of ophthalmology through his innovative work with avermectin and milbemycin compounds. With a total of 3 patents to his name, Bouissou's inventions are paving the way for new treatments in eye care.
Latest Patents
One of Bouissou's latest patents focuses on the administration of avermectin and milbemycin compounds for the treatment of ophthalmic pathologies. This patent highlights the utility of compounds from the avermectin family, particularly ivermectin, in treating conditions such as ocular rosacea. His work in this area demonstrates a commitment to improving patient outcomes through innovative pharmaceutical solutions.
Career Highlights
Philippe Bouissou is associated with Galderma S.A., a company renowned for its dedication to dermatological and aesthetic solutions. His role at Galderma has allowed him to leverage his expertise in developing treatments that address complex ophthalmic issues. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Throughout his career, Bouissou has collaborated with talented professionals, including Alexandre Kaoukhov and Christophe Villard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Philippe Bouissou's work exemplifies the impact of innovation in the field of ophthalmology. His patents and collaborations reflect a dedication to enhancing treatment options for patients. Through his efforts, Bouissou continues to contribute to the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
